Get the Stockscreener App
5.67
2.53%
0.14
After Hours:
5.72
0.05
+0.88%
Abcellera Biologics Inc stock is traded at $5.67, with a volume of 4.27M.
It is up +2.53% in the last 24 hours and up +26.85% over the past month.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
See More
Previous Close:
$5.53
Open:
$5.645
24h Volume:
4.27M
Relative Volume:
0.75
Market Cap:
$1.69B
Revenue:
$38.03M
Net Income/Loss:
$-146.40M
P/E Ratio:
-10.90
EPS:
-0.52
Net Cash Flow:
$-121.38M
1W Performance:
-3.41%
1M Performance:
+26.85%
6M Performance:
+136.25%
1Y Performance:
+118.92%
1-Day Range:
$5.5816
$5.76
1-Week Range:
$5.46
$6.515
52-Week Range:
$1.8906
$6.515
Abcellera Biologics Inc Stock (ABCL) Company Profile
Name
Abcellera Biologics Inc
Sector
Industry
Phone
(604) 559-9005
Address
150 W 4TH AVENUE, VANCOUVER
Compare ABCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
5.67 | 1.65B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | Leerink Partners | Outperform |
| Aug-20-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-22-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-06-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-13-23 | Resumed | Piper Sandler | Overweight |
| Feb-28-23 | Initiated | Cowen | Outperform |
| Dec-15-22 | Initiated | Goldman | Buy |
| Nov-16-22 | Initiated | Truist | Buy |
| Dec-21-21 | Initiated | The Benchmark Company | Buy |
| Nov-19-21 | Initiated | Piper Sandler | Overweight |
| Jan-05-21 | Initiated | BMO Capital Markets | Outperform |
| Jan-05-21 | Initiated | Berenberg | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Outperform |
| Jan-05-21 | Initiated | SVB Leerink | Outperform |
| Jan-05-21 | Initiated | Stifel | Buy |
View All
Abcellera Biologics Inc Stock (ABCL) Latest News
Analyzing recovery setups for AbCellera Biologics Inc. investors2025 Trading Recap & Capital Efficiency Focused Ideas - newser.com
How to use a screener to detect AbCellera Biologics Inc. breakouts2025 Price Action Summary & Step-by-Step Trade Execution Guides - newser.com
Custom watchlist performance reports with AbCellera Biologics Inc.Trade Ideas & Low Risk Investment Opportunities - newser.com
What’s next for AbCellera Biologics Inc. stock priceJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Will AbCellera Biologics Inc. stock maintain momentum in 2025Market Risk Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How AbCellera Biologics Inc. (8QQ) stock behaves in tightening cyclesEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Is AbCellera Biologics Inc. a candidate for recovery play2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
How AbCellera Biologics Inc. stock benefits from tech adoption2025 Year in Review & Daily Momentum Trading Reports - newser.com
AbCellera Biologics Hits New 52-Week High of $6.51 - Markets Mojo
AbCellera Biologics (NASDAQ:ABCL) Hits New 1-Year HighStill a Buy? - MarketBeat
Is now a turning point for AbCellera Biologics Inc.Earnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Why AbCellera Biologics Inc. (8QQ) stock could rally stronglyNew Guidance & Free Technical Pattern Based Buy Signals - newser.com
Analyzing AbCellera Biologics Inc. with risk reward ratio chartsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Real time alert setup for AbCellera Biologics Inc. performanceStop Loss & Weekly High Potential Stock Alerts - newser.com
Does AbCellera Biologics Inc. qualify in momentum factor screening2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Is AbCellera Biologics Inc. (8QQ) stock cheap vs fundamentalsWeekly Trend Report & Safe Swing Trade Setups - newser.com
Is AbCellera Biologics Inc. (8QQ) stock a top dividend aristocrat candidateEarnings Beat & Expert Curated Trade Setups - newser.com
AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 7.9%Here's What Happened - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 - PharmiWeb.com
AbCellera Biologics: Entering Growth Phase After A Pause (NASDAQ:ABCL) - Seeking Alpha
AbCellera Biologics Inc. recovery potential after sell off2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Is AbCellera Biologics Inc. stock a dividend growth opportunity2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Forecasting AbCellera Biologics Inc. price range with options dataJuly 2025 Short Interest & Technical Entry and Exit Tips - newser.com
Should you hold or exit AbCellera Biologics Inc. nowWeekly Stock Summary & Daily Stock Trend Reports - newser.com
Statistical indicators supporting AbCellera Biologics Inc.’s strengthQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Leading vs lagging indicators on AbCellera Biologics Inc. performanceTrade Exit Summary & Short-Term High Return Ideas - newser.com
Is AbCellera Biologics Inc. stock safe for conservative investors2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
Published on: 2025-10-05 03:44:08 - newser.com
AbCellera Biologics Hits Day High with 8.17% Surge in Stock Price - Markets Mojo
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline - Yahoo
How high can AbCellera Biologics Inc. stock goRate Cut & Technical Pattern Recognition Alerts - newser.com
Using RSI to spot recovery in AbCellera Biologics Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Published on: 2025-10-03 03:02:14 - newser.com
Is AbCellera Biologics Inc. (8QQ) stock in buy zone after pullback2025 Historical Comparison & AI Driven Stock Movement Reports - newser.com
Abcellera Biologics Inc Stock (ABCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):